mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0003 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
0.0003 |